Cite

HARVARD Citation

    De Giorgi, U. et al. (2019). Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme. BJU international. pp. 98-105. [Online]. 
  
Back to record